Source: Risk Management and Healthcare Policy. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, RECEPTORES DE DROGA, COGNIÇÃO, HUMOR, POLÍTICAS PÚBLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges. Risk Management and Healthcare Policy, v. 14, p. 901-910, 2021Tradução . . Disponível em: https://doi.org/10.2147/RMHP.S300656. Acesso em: 07 out. 2025.APA
Santos, R. G. dos, Bouso, J. C., Rocha, J. M., Rossi, G. N., & Hallak, J. E. C. (2021). The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges. Risk Management and Healthcare Policy, 14, 901-910. doi:10.2147/RMHP.S300656NLM
Santos RG dos, Bouso JC, Rocha JM, Rossi GN, Hallak JEC. The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges [Internet]. Risk Management and Healthcare Policy. 2021 ; 14 901-910.[citado 2025 out. 07 ] Available from: https://doi.org/10.2147/RMHP.S300656Vancouver
Santos RG dos, Bouso JC, Rocha JM, Rossi GN, Hallak JEC. The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges [Internet]. Risk Management and Healthcare Policy. 2021 ; 14 901-910.[citado 2025 out. 07 ] Available from: https://doi.org/10.2147/RMHP.S300656